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Effect of intraoperative fluid 
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Study Group*
This study aimed to investigate the effect of intraoperative fluid volume on the postoperative 
ileus (POI) recovery period. A retrospective review of the Korean robot‑assisted radical cystectomy 
database identified 718 patients who underwent robot‑assisted radical cystectomy (RARC). 
Regression analyses were performed to identify the associations between the amount of 
intraoperative fluid administration (crystalloid/colloid/total), POI period (time to flatus/bowel 
movements), and length of hospital stay (LOS) after adjusting for covariates. In addition, we analyzed 
the risk factors for gastrointestinal complications and prolonged POI using a logistic regression model. 
An increasing volume of the administered crystalloid/total fluid was associated with prolonged POI 
(crystalloid  R2 = 0.0725 and P < 0.0001; total amount  R2 = 0.0812 and P < 0.0001), and the total fluid 
volume was positively associated with the LOS  (R2 = 0.099 and P < 0.0001). The crystalloid amount was 
a risk factor for prolonged POI (P < 0.001; odds ratio, 1.361; 95% confidence interval, 1.133–1.641; 
P < 0.001). In the context of RARC, increased intravenous fluids are associated with prolonged POI and 
longer LOS.
Since its introduction in 2003, robot-assisted radical cystectomy (RARC) is a minimally invasive technique 
that has been increasingly used worldwide. It shows comparable results in terms of oncologic and periopera-
tive  outcomes1,2. Recent studies have shown that RARC improves perioperative morbidity and facilitates early 
 recovery3,4.
Gastrointestinal complications are the primary complications of both RARC and open surgical approach. 
Postoperative ileus (POI), which occurs in approximately 20% of patients, is commonly implicated for delayed 
recovery and increased risk of postoperative  complications5. Weak and ineffective peristalsis associated with POI 
can lead to accumulation of gastrointestinal secretion, causing abdominal distension and vomiting; prolonged 
OPEN
1Department of Urology, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, 
Korea. 2Department of Urology, Seoul National University College of Medicine, Seoul, Korea. 3Department of 
Urology, Kyungpook National University School of Medicine, Daegu, Korea. 4Department of Urology, Kyung 
Hee University School of Medicine, Seoul, Korea. 5Department of Urology, Pusan National University Yangsan 
Hospital, Yangsan, Korea. 6Department of Urology, College of Medicine, Busan Paik Hospital, Inje University, 
Busan, Korea. 7Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 
Seoul, Korea. 8Department of Urology, College of Medicine, Seoul St. Mary’s Hospital, The Catholic University of 
Korea, Seoul, Korea. 9Department of Urology, Severance Hospital, Yonsei University College of Medicine, Seoul, 
Korea. 10Department of Urology, Hallym University Kangnam Sacred Heart Hospital, Hallym University School 
of Medicine, Seoul, Korea. 11Department of Urology, Hallym University Sacred Heart Hospital, Hallym University 
College of Medicine, Anyang, Korea. 12Department of Urology, Hanyang University College of Medicine, Seoul, 
Korea. 13Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea. *A list of authors 
and their affiliations appears at the end of the paper. *email: urojin@snu.ac.kr; mdksh@korea.ac.kr
2
Vol:.(1234567890)
Scientific Reports |        (2021) 11:10522  | https://doi.org/10.1038/s41598-021-89806-z
www.nature.com/scientificreports/
POI even requires parenteral  nutrition6. POI is traditionally considered inevitable after major abdominal surgery, 
leading to increased patient morbidity, hospital  costs7,8, and 30-day readmission  rates9.
A complex interplay between neurogenic, inflammatory, fluid and electrolyte, and pharmacologic compo-
nents plays a role in the development of POI. Among these, fluid and electrolyte imbalances can be managed 
with intraoperative care. However, proper perioperative fluid management strategies for patients undergoing 
elective surgery have not yet been  established10–13. Several studies have reported that hypervolemic management 
may result in bowel edema, prolong the recovery of bowel function, disrupt tissue oxygenation, and adversely 
affect the healing of anastomotic  sites14–17. On the other hand, fluid restriction has been shown to accelerate the 
recovery of bowel function and facilitate the early intake of oral diet; but owing to the heterogeneity of these 
studies and the lack of a precise definition of “restricted,” the real impact of fluid restriction on the POI period 
is yet to be  established18,19. In an attempt to overcome this limitation, we attempted to determine the independ-
ent effect of the intraoperative volume on the POI period and length of hospital stay (LOS) through regression 
analysis, after adjusting for other covariates.
The Korean Robot-Assisted Radical Cystectomy (KORARC) study group has a quality assurance database 
comprising > 750 RARC patients. In this study, the KORARC database was queried for the oncologic and func-
tional outcomes of a large series of patients who underwent RARC. Using this database, we tested the hypothesis 
that unrestricted fluid management in patients during operation could be associated with prolonged bowel 
function convalescence.
Materials and methods
Study population. The prospectively collected KORARC database comprises over 750 patients from 11 
tertiary referral institutions (21 surgeons) who were treated with RARC between April 2007 and October 2019. 
Study participants included patients with recurrent/multiple or high-grade superficial or muscle-invasive blad-
der cancer without evidence of metastatic disease on preoperative imaging. Further, eligible patients medically 
cleared for radical cystectomy with pelvic lymph node dissection (PLND), were aged ≥ 18 years, and had clini-
cal stage Ta–T4/N0–N3/M0. We excluded study participants with evidence of metastasis who had previously 
undergone abdominal surgery or pelvic radiation therapy. The KORARC database is a web-based electronic 
database and is a brain-child of the Korean Society of Endourology and Robotics. All 718 patients enrolled in 
this study received perioperative patient care according to the previously established enhanced recovery after 
surgery (ERAS)  program20–22. However, we adopted a slightly modified ERAS program based on special circum-
stances in Korea. As per anesthesiologists’ requirements, all patients fasted from 12 AM of the day preceding the 
surgery; a policy that applies to almost all hospitals in South Korea. Further, we could not administer alvimo-
pan, a μ-receptor opioid antagonist, that has been reported to be effective in bowel function recovery in several 
studies, because it has not been introduced in Korea yet. Most of the other guidelines were followed, such as the 
avoidance of mechanical bowel preparation, avoidance of nasogastric tube insertion or its early removal, early 
ambulation, early feeding (within 24 h post-surgery), and use of multimodal analgesia to minimize opioid use.
Definitions. Based on a systematic review, the definition of POI was proposed as follows: “POI” is defined 
as the bowel dysfunction that occurs immediately after surgery, and recovery of POI refers to a case in which 
flatus or stool is passed and oral diet is tolerated; “prolonged POI” can be defined as a case in which one or more 
of following conditions are applicable on or before postoperative day 7 without POI resolution as per the above-
mentioned criteria: (1) nausea or vomiting, (2) inability to tolerate oral diet for the preceding 24 h; (3) no flatus 
or stool passage for the preceding 24 h (4) abdominal distension, and/or (5) radiologic bowel distension sign 
with no mechanical  obstruction23.
Endpoints. The primary endpoint was the correlation between the intravenous fluid volume (crystalloid/
colloid/total), POI period, and LOS, after controlling for confounders. Regression analyses were performed to 
identify the combination of crystalloid volume, colloid volume, total fluid volume, and LOS associated with 
prolonged POI. The secondary endpoint was identification of gastrointestinal complications and prolonged POI. 
Multivariate logistic regression was used to assess the following potential predictors: age, sex, body surface area, 
body mass index, corporeal method (intracorporeal or extracorporeal), urinary diversion type (orthotopic blad-
der substitution or ileal conduit), crystalloid/colloid injection amount, operation time, American Society of 
Anesthesiologists (ASA) score, PLND extent, and tumor-node-metastasis (TNM) stage.
Statistical analyses. Continuous variables are expressed as median (interquartile range [IQR]) or as a 
number (percentage) of cases. Categorical variables are reported as numbers and percentages. Pearson’s cor-
relation coefficients were used for statistical comparisons of continuous variables. Logistic regression analysis 
was performed to analyze the predictors of complications. Simple and multiple linear regression analyses were 
performed. All analyses were performed using the Statistical Package for the Social Sciences (SPSS) version 20.0 
(IBM Corp., Armonk, N.Y., USA) and SigmaPlot (version 13.0; SYSTAT Inc., San Jose, CA, USA). Results were 
considered statistically significant if the P-value was less than 0.05.
Ethics statement. This study conformed to the standards of the Declaration of Helsinki and the current 
ethical guidelines. The study protocol was reviewed and approved by the Institutional Review Board of Korea 
University Hospital (No. 2019AN0102). Written informed consent was obtained from all the study participants 
prior to their enrolment.
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Results
Baseline characteristics. The average age of patients was 65 years (IQR, 60.0–73.0), of which 615 (85.0%) 
were men; 57 (7.9%) had an ASA score > 3 (Table 1). As for the urinary diversion type, ileal conduit constituted 
39.0% of cases; orthotopic bladder substitution, 55.0%; and continent cutaneous urinary diversion, 6.0%. The 
distribution of corporeal methods was as follows: intracorporeal, 15.3% and extracorporeal, 84.7%. The total 
number of patients who underwent standard PLND and extended type PLND was 151 (21.1%) and 397 (55.2%), 
respectively. Regarding perioperative outcomes, the median operation time was 433 min (IQR, 330–520), and 
the median time to flatus and bowel movement was 72 (IQR, 47–90) and 109 (IQR, 84–138) hours, respectively. 
The median LOS was 16 days (IQR, 13–22).
Intraoperative intravenous fluids and preoperative laboratory results. The volumes of the 
crystalloid, colloid, and blood products administered are shown in Table  2. The overall median volumes of 
intravenous fluid used were as follows: total volume, 2850 mL (IQR, 2100–4012); crystalloid, 2600 mL (IQR, 
1800–3500); and colloid, 390 mL (IQR, 0–500 mL). All patients on crystalloid fluids received 1450 mL of lactated 
ringer’s solution (IQR, 900–2490). Among the colloid-administered patients, 308 patients received 700 mL of 
synthetic colloids (IQR, 500–900).
Common gastrointestinal tract complications. The overall complication rate was 56%, and 15% of the 
complications were observed within 30 days (105 patients) of surgery. The incidence of major and minor com-
plications was 18% (129 patients) and 38% (273 patients), respectively. Among all categories, the gastrointestinal 
complication rate was 24% (173 patients), with 31% (47 patients) experiencing high-grade complications. The 
most common gastrointestinal complications encountered were prolonged POI (93 patients, 13%), small bowel 
obstruction (29 patients, 4%), nausea/vomiting (27 patients, 4%), and diarrhea (37 patients, 5%) (Table 3).
Association between intravenous fluid amount, POI period, and length of hospital stay. The 
POI period was positively associated with crystalloid (γ = 0.227, P < 0.001) and total intravenous fluid volumes 
(γ = 0.242, P < 0.001), and not associated with colloid volumes. LOS was positively associated with crystalloid 
(γ = 0.208, P < 0.001), colloid (γ = 0.097, P = 0.010), and total intravenous fluid volumes (γ = 0.211, P < 0.001).
Table 1.  Baseline characteristics of patients and perioperative parameters. Values are presented as number (%) 
or median. ASA American Society of Anesthesiologists, BMI body mass index, BSA body surface area, CCUD 
continent cutaneous urinary diversion, IQR interquartile range, OBS orthotopic bladder substitution, PLND 
pelvic lymph node dissection.
Baseline characteristics Values n = 718 IQR




BMI, kg/m2 24.1 22.2–26.2
BSA 1.8 1.6–1.9
ASA score ≥ 3 57 (7.9)
Type of urinary diversion







 Extended PLND 397 (55.2)
 Standard PLND 151 (21.1)
 Limited PLND 21 (2.9)
 None 149 (20.8)
Perioperative outcomes
 Operation time (min) 433 330–520
 Time to flatus (h) 72 47–90
 Time to bowel movement (h) 109 84–138
 Length of hospital stay (days) 16 13–22
4
Vol:.(1234567890)
Scientific Reports |        (2021) 11:10522  | https://doi.org/10.1038/s41598-021-89806-z
www.nature.com/scientificreports/
Regression analysis. On multivariate linear regression analyses, the total intraoperative intravenous 
volume and crystalloid volume were significantly positively associated with the time to flatus (total volume, 
P < 0.0001; crystalloid, P < 0.0001; Fig. 1a, b). In addition, the total intraoperative intravenous volume was the 
only significant factor for LOS (P < 0.0001; Fig. 2).
Predictive factors of gastrointestinal complication and prolonged POI. On logistic regression 
analysis, the type of diversion technique was a significant predictor of gastrointestinal tract complications (odds 
ratio [OR], 1.985; 95% confidence interval [CI], 1.198–3.288; P = 0.008), while the fluid volume was not statisti-
cally significant. As for prolonged POI, the crystalloid amount (OR, 1.361; 95% CI, 1.133–1.641; P < 0.001) was 
statistically significant (Table 4). In addition, other clinical factors, such as operation time, age, sex, ASA score, 
PLND extent, and TNM stage (not mentioned in Table 4), did not show statistical significance (Table 4).
Discussion
The main results of this multi-institutional trial provide evidence for the association of POI period with the 
volume of intravenous fluid administered during RARC, a topic that has long been debated. The present study 
analyzed the impact of intraoperative fluid volume on the POI period in a cohort of 718 patients who underwent 
RARC, using regression analysis, on a large-scale, prospectively collected, KORARC database of patients. As 
hypothesized, we found that liberal intraoperative fluid volume was associated with prolonged POI and longer 
LOS, which implies that stringent fluid management could help decrease the postoperative recovery time after 
RARC.
The main strength of this study was that it specifically evaluated the independent impact of intraoperative 
fluid volume on the recovery of bowel function in the context of complex radical surgery, limiting the risk of 
bias due to several intraoperative confounding factors. On regression analyses, our results confirmed that the 
administration of less fluid produced small, but significant postoperative recovery advantages  (R2 = 0.0812 for 
POI and 0.099 for LOS).
The goal of intraoperative fluid management is to create a “zero” fluid balance at the end of the surgery without 
complications. For physiological maintenance, enough fluid should be given to maintain the patient’s weight 
prior to surgery, and for replacing fluid loss through urine, sweat, and other  routes24. The volume of balanced 
Table 2.  Intraoperative intravenous fluids and primary preoperative laboratory results. Values are presented as 
number (%) or median. CRP C-reactive protein, GFR glomerular filtration rate, IQR interquartile range, LDH 
lactate dehydrogenase, PLT platelet.
Baseline characteristics Values Injected patient no. n = 718 IQR
Total volume of intravenous fluid, mL 2850 2100–4012
Total volume of crystalloid, mL 2600 1850–3500
Total volume of colloid, mL 390 0–500
Crystalloid, mL
 Normal saline 1000 261 575–1700
 Lactated Ringer’s solution 1450 446 900–2490
 Plasma solution 1700 456 1000–2500
 5%/10% dextrose solution 150 15 50–200
 0.45% NaCl 600 1 –
 0.9% NaCl 100 2 –
Colloid, mL
 5% albumin 250 18 250–450
 Synthetic colloids 700 308 500–900
Blood products, mL
 Packed red blood cells 500 111 320–655
 Fresh frozen plasma 360 6 260–500
 Platelet concentrate 30 5 –
Estimated blood loss (mL) 450 300–650
Preoperative laboratory results Values IQR
 Hb (g/dL) 12.8 11.3–14.1
 Alb (g/dL) 4.1 3.6–4.4
 GFR (mL/min) 77.1 61–91.3
 LDH (IU/L) 318 196–402
 CRP (mg/L) 0.7 0.1–18.2
 PLT (×  103/μL) 221 178.3–270.8
 Neutrophil (%) 60.7 53.7–69.5
 Lymphocyte (%) 27.5 19.7–34.3
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crystalloid solution administered should not exceed 3 mL  kg-−1  h−1, because during major abdominal surgery, 
only 0.5–1.0 mL  kg−1  h−1 of water is lost due to evaporation (lower than originally thought)25. Clinically, bowel 
edema, which results in ileus, is the most common symptom occurring secondary to excessive fluid therapy 
during RARC, and tends to be more prominent under the care of inexperienced anesthesiologists. RARC is a 
relatively complex operation that takes approximately 6 h on average (the volume of crystalloid administered 
Figure 1.  Linear regression analysis of the associations between intraoperative intravenous fluids and the 
postoperative ileus period as time to flatus; (a) total fluids, (b) crystalloid (blue long dash line—95% confidence 
band, red short dash line—95% prediction band).
6
Vol:.(1234567890)
Scientific Reports |        (2021) 11:10522  | https://doi.org/10.1038/s41598-021-89806-z
www.nature.com/scientificreports/
increases with the duration of surgery), and pneumoperitoneum and head-down positions make fluid therapy 
indices difficult to interpret. Several studies have found that perioperative fluid overload is associated with 
increased  morbidity26, and it has been demonstrated that avoiding fluid overload leads to improved outcomes 
not only in urology, but also in major gastrointestinal  surgery27. In the Multicenter Danish study, when fluid was 
restricted during surgery, postoperative complications were reduced by almost half regardless of the volume of 
fluid infusion before and after  surgery10. Lobo et al.28 reported that fluid overload during elective surgery was 
related to increased time until the first passage of flatus or stool, increased gastric emptying time, and increased 
time to tolerance of solid food.
The reconstructive portion of the RARC for bowel resection and anastomosis is closely associated with POI. 
Marjanovic et al. demonstrated that hypervolemia increases intravascular hydrostatic pressure and causes dam-
age to the endothelial glycocalyx, a mediator that induces fluid retention in the interstitial  space17,29,30. In their 
animal model, a distinct submucosal pale band was found in the hypervolemia group, and a narrow and dense 
Figure 2.  Regression curves on the analysis of the association between intraoperative intravenous total fluids 
and length of hospital stay.
Table 3.  Summary of the common gastrointestinal tract complications experienced.
n = 718 no. (%)
Total complication rate 402 (56)
 Within 30 days 105 (15)
 Within 90 days 297 (41)
Major complication rate (Clavien-Dindo grades 3–5) 129 (18)
Minor complication rate (Clavien-Dindo grades 1–2) 273 (38)
Gastrointestinal complication rate
 Overall 173 (24)
 Major complication rate (Clavien grades 3–5) 47 (31)
Prolonged postoperative ileus 93 (13)
Small bowel obstruction 29 (4)
Diarrhea 37 (5)
Others (hematochezia, stomach/duodenal ulcer) 9 (1)
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submucosal layer was found in the volume-restriction group. In addition, the volume of crystalloid infusion 
during surgery was reported to have a significant effect on the structural and functional stability of the intestinal 
anastomosis in the early postoperative period.
However, there are a few issues in our findings that need to be addressed. First, in our results, colloids, unlike 
crystalloids, were not a risk factor for POI. Some studies have found a greater influence of colloids on the fluid 
resuscitation of critically ill patients compared with crystalloids; but studying how colloids might impact POI 
is largely a novel area of  research31,32. Crystalloid have a hemodilution effect, while colloids have the ability to 
maintain osmotic pressure in the vasculature; hence, even with the same volume, colloids are expected to induce 
lesser bowel edema.
We previously investigated whether intracorporeal urinary diversion (ICUD) has more clinical benefits than 
extracorporeal urinary diversion (ECUD)33. Our study showed significantly better results for ICUD compared to 
ECUD in terms of the overall and gastrointestinal complication rates, which is consistent with the International 
Robotic Cystectomy Consortium  data34. The duration for which the peritoneum is exposed to the external envi-
ronment is proportional to intestinal inflammation and oxidative stress response, and these factors could cause 
the delayed restoration of bowel  function35. However, in our study, the corporeal type did not significantly affect 
the occurrence of gastrointestinal complications (P = 0.407) or prolonged POI (P = 0.745). This is attributed to the 
following reasons: The anesthesiologist of each operation was different, which resulted in differing strategies of 
fluid therapy administration. Moreover, our data did not reflect the clinical experience of surgeons, which means 
that a few outcomes of surgeons who had not overcome the learning curve yet were included.
Our study has several limitations. First, further fluid management-related measures, such as urine output, 
were not measured. However, owing to the surgical principles of RARC that include bilateral ureter clamping in 
the early stage of surgery, the impact might be insignificant and can be a confounding factor considering that it 
is difficult to accurately account for. Certainly, it should be acknowledged that various surgical situations warrant 
varying interventions and different surgeons/anesthesiologists, potentially limiting the generalizability of these 
results in centers with different principles of perioperative care.
In conclusion, intravenous fluid administration during surgery is an easily modifiable part of RARC, and 
intense collaboration between urologists and anesthesiologists is necessary to encourage optimal gastrointestinal 
recovery. Within its limitations, this study shows that an increased volume of fluid received during RARC may 
impair return to normal bowel function. To maximize the advantage of RARC as a minimally invasive operation, 
careful monitoring is required to control the amount of fluid infusion during surgery and to avoid fluid overload.
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